MALONE JOHN C
SC 13D, 1997-10-01
Previous: SEAMED CORP, 10-K, 1997-10-01
Next: GOLF TECHNOLOGY HOLDING INC, 8-K, 1997-10-01



<PAGE>
 
                      SECURITIES AND EXCHANGE COMMISSION
                             Washington, DC  20549

                                 Schedule 13D

                   Under the Securities Exchange Act of 1934
                               (Amendment No. 3)

                       TCI SATELLITE ENTERTAINMENT, INC.
                                (Name of Issuer)

                     Series A Common Stock, $1.00 par value
                     Series B Common Stock, $1.00 par value
                     --------------------------------------
                        (Title of Classes of Securities)

                        Series A Common Stock  872298104
                        Series B Common Stock  872298203
                        --------------------------------
                                (CUSIP Numbers)

                              Dr. John C. Malone
                         c/o Tele-Communications, Inc.
   Terrace Tower II, 5619 DTC Parkway, Englewood, CO  80111, (303-267-5500)
                 (Name, Address and Telephone Number of Person
               Authorized to Receive Notices and Communications)

                              September 23, 1997
                              ------------------
                      (Date of Event which Requires Filing
                               of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b) (3) or (4), check the following box: [_].

Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).



                          Exhibit Index is on Page 6


                                      -1-
<PAGE>
 
Cusip No. -  Series A Common Stock  872298104
Cusip No. -  Series B Common Stock  872298203

 
- --------------------------------------------------------------------------------
     (1)          Names of Reporting Persons S.S. or I.R.S. Identification Nos.
                  of Above Persons

                  Dr. John C. Malone
 
- --------------------------------------------------------------------------------
     (2)          Check the Appropriate Box if a Member of a Group
                                                                    (a)  [ ]
                                                                    (b)  [ ]

- --------------------------------------------------------------------------------
     (3)          SEC Use Only
 

- --------------------------------------------------------------------------------
     (4)          Source of Funds
                  PF, AF
 
- --------------------------------------------------------------------------------
     (5)          Check if Disclosure of Legal Proceedings is Required Pursuant
                  to Items 2(d) or 2(e)           [_]

- --------------------------------------------------------------------------------
     (6)          Citizenship or Place of Organization
                  U.S.
 
- --------------------------------------------------------------------------------
Number of         (7)  Sole Voting Power          756,061 Shares of Series A*
                                                  3,439,958 Shares of Series B**
Shares Bene-
                       ---------------------------------------------------------
 ficially         (8)  Shared Voting Power        0 Shares
 Owned by
                       ---------------------------------------------------------
Each Report-      (9)  Sole Dispositive Power     756,061 Shares of Series A*
                                                  3,439,958 Shares of Series B**
ing Person
                       ---------------------------------------------------------
  With            (10) Shared Dispositive Power   0 Shares
                                    
- --------------------------------------------------------------------------------
     (11)         Aggregate Amount Beneficially Owned by Each Reporting Person

                       756,061 Shares of Series A*
                       3,439,958 Shares of Series B**
 
- --------------------------------------------------------------------------------
     (12)         Check if the Aggregate Amount in Row (11) Excludes Certain 
                  Shares                                              [_] **
 
- --------------------------------------------------------------------------------
     (13)         Percent of Class Represented by Amount in Row (11)***

                       Series A Common Stock      1.3%
                       Series B Common Stock      40.6%
 
- --------------------------------------------------------------------------------
     (14)         Type of Reporting Person

                       IN
_____________________________

*Including the 556,061 shares beneficially owned by Dr. Malone, together with
the additional 200,000 shares Dr. Malone would acquire upon the exercise of
stock options granted in tandem with stock appreciation rights of which options
for 120,000 shares are currently exerciseable, but does not include shares of
Series A Common Stock issuable upon conversion of shares of Series B Common
Stock. (See Items 3 and 5 of the Statement)
**Includes 117,300 shares of Series B Common Stock beneficially owned by Dr.
Malone's spouse, to which Dr. Malone disclaims any beneficial ownership thereof.
(See Item 5 of the Statement).
***Each share of Series A Common Stock is entitled to one vote per share and
each share of Series B Common Stock is entitled to 10 votes per share.
Accordingly, when these series of stock are aggregated, the Reporting Person may
be deemed to beneficially own voting equity securities of the Issuer
representing approximately 24.6% of the voting power of the Issuer.


                                      -2-
<PAGE>
 
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                 SCHEDULE 13D
                               (Amendment No. 3)

                                 Statement of

                              DR. JOHN C. MALONE

                       Pursuant to Section 13(d) of the
                        Securities Exchange Act of 1934

                                 in respect of

                       TCI SATELLITE ENTERTAINMENT, INC.
                         (Commission File No. 0-21317)

ITEM 1.   Security and Issuer
          -------------------

          Dr. John C. Malone hereby amends and supplements his Statement on
Schedule 13D (the "Statement"), with respect to the Series A Common Stock, par
value $1.00 per share (the "Series A Stock"), and the Series B Common Stock, par
value $1.00 per share (the "Series B Stock" and together with the Series A
Stock, the "Issuer Common Stock"), of TCI Satellite Entertainment, Inc., a
Delaware corporation (the "Issuer").  The principal executive offices of the
Issuer are located at 8085 South Chester, Suite 300, Englewood, Colorado 80112.
Unless otherwise indicated, capitalized terms used but not defined herein shall
have the meanings assigned to such terms in the Statement.

          Dr. Malone is filing this Amendment No. 3 to the Statement to report
an acquisition of shares of Series A Stock and a disposition of shares of Series
B Stock.

ITEM 3.   Source and Amount of Funds or Other Consideration
          -------------------------------------------------

          Item 3 of the Statement is hereby amended and supplemented by adding
the following:

          Pursuant to the terms of an Exchange Agreement, dated as of September
23, 1997 (the "Agreement"), among Dr. Malone, Tele-Communications, Inc. and
Kearns-Tribune Corporation ("KTC"), KTC exchanged 911,250 shares of Series B
Stock owned by KTC for 911,250 shares of Series A Stock owned by Dr. Malone.
The foregoing description of the exchange is qualified in its entirety by
reference to the Agreement attached to this Amendment No. 3 to the Statement as
Exhibit 7(C) and incorporated herein by this reference.


                                      -3-
<PAGE>
 
ITEM 4.   Purpose of Transaction
          ----------------------

          Item 4 of the Statement is hereby amended and supplemented by adding
the following:

          Dr. Malone exchanged 911,250 shares of his Series A Stock for an equal
number of shares of Series B Stock, all as described in Item 3 above, to
increase his voting power with respect to the Issuer.

ITEM 5.   Interest in Securities of the Issuer
          ------------------------------------

          Item 5(a) of the Statement is hereby amended and supplemented by
adding the following:

          Dr. Malone beneficially owns (without giving effect to the conversion
of Series B Stock for Series A Stock): (a) 756,061 shares of Series A Stock,
which includes interests in shares held by the trustee of the Issuer's Employee
Stock Purchase Plan, and options for 200,000 shares of which options for 120,000
shares are currently exerciseable and represents 1.3% of the outstanding shares
of Series A Stock; and (b) 3,439,958 shares of Series B Stock, which represents
40.6% of the outstanding shares of Series B Stock. The foregoing percentage
interests are based on the outstanding share numbers provided by the Issuer as
of August 31, 1997 (adjusted for Dr. Malone's options as if exercised in full),
as follows: 58,420,802 shares of Series A Stock and 8,465,564 shares of Series B
Stock. When these series of stock are aggregated, Dr. Malone may be deemed to
beneficially own voting equity securities of the Issuer representing 
approximately 24.6% of the voting power of the Issuer.

          Item 5(c) of the Statement is hereby amended and supplemented by
adding the following:

          Except as described in Item 3 above on Dr. Malone's exchange of
911,250 shares of Series A Stock for an equal number of shares of Series B
Stock, neither Dr. Malone nor, to his knowledge, his spouse has executed
transactions in the Issuer's Common Stock during the past 60 days.

ITEM 7.   Material to be Filed as Exhibits
          --------------------------------

          C.  Exchange Agreement, dated as of September 23, 1997, among Dr. John
              C. Malone, Tele-Communications, Inc. and Kearns-Tribune
              Corporation.


                                      -4-
<PAGE>
 
                                   SIGNATURE

          After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Amendment No. 3 to the Statement
is true, complete and correct.


September 29, 1997                             /s/  Dr. John C. Malone
                                               -------------------------------
                                               Dr. John C. Malone




                                      -5-
<PAGE>
 
                                 EXHIBIT INDEX
                                 -------------
<TABLE>
<CAPTION>
 
EXHIBIT                             EXHIBIT                            PAGE
- -------                             -------                            ----
NUMBER
- ------

<S>          <C>                                                       <C>
 7(C)        Exchange Agreement dated as of September 23, 1997,         7
             among Dr. John C. Malone, Tele-Communications, Inc. 
             and Kearns-Tribune Corporation.
</TABLE>


                                      -6-

<PAGE>
 
                                                                    EXHIBIT 7(C)



                               EXCHANGE AGREEMENT


          Exchange Agreement, dated as of September 23, 1997 (this "Agreement"),
among Tele-Communications, Inc., a Delaware corporation ("TCI"), Kearns-Tribune
Corporation, a Utah corporation and a wholly-owned subsidiary of TCI ("KTC"),
and John C. Malone ("Malone").

                                  WITNESSETH:

          WHEREAS, on July 31, 1997, TCI and KTC consummated a merger
transaction (the "KTC Merger") pursuant to which KTC became a wholly-owned
subsidiary of TCI;

          WHEREAS, at the time of the KTC Merger, the assets of KTC included,
among other things, 879,249 shares of Series A Common Stock, par value $1.00 per
share ("Series A Common Stock"), of TCI Satellite Entertainment, Inc., a
Delaware corporation ("TSAT"), and 911,250 shares of Series B Common stock, par
value $1.00 per share ("Series B Common Stock"), of TSAT;

          WHEREAS, each of the Boards of Directors of TCI and KTC have
determined that it is in the best interest of their respective corporations to
exchange all of the shares of Series B Common Stock owned by KTC for an equal
number of shares of Series A Common Stock owned by Malone, and the parties are
entering into this Agreement for that purpose.

          NOW THEREFORE, in consideration of the premises and intending to be
legally bound, the parties hereto hereby agree as follows:

          1.   Exchange.
               ---------

          (a)  At the Closing (as defined herein), and subject to the terms and
conditions hereinafter set forth, KTC shall exchange (the "Exchange") the
911,250 shares of Series B Common Stock owned by KTC (the "KTC Series B Shares")
for 911,250 shares of Series A Common Stock owned by Malone (the "Malone Series
A Shares").

          (b)  At the Closing, KTC shall deliver, or cause to be delivered, to
Malone, against delivery of certificates representing the Malone Series A
Shares, certificates representing the KTC Series B Shares.  The certificates
representing KTC Series B Shares and the Malone Series A Shares shall be
accompanied by duly executed stock powers in blank and with all requisite stock
transfer stamps affixed thereto.

          2.   Closing.  The closing of the Exchange (the "Closing") shall 
               --------  
(unless the parties hereto agree otherwise) take place at the offices of TCI,
5619 DTC Parkway, Englewood, Colorado, at a date and time to be mutually agreed
upon by TCI and Malone.

          3.   Representations and Warranties of the Representative.  Each of 
               -----------------------------------------------------       
TCI and KTC, jointly and severally, represents and warrants to Malone as
follows:


                                       7
<PAGE>
 
          (a)  Power and Authority. Each of TCI and KTC has the requisite
corporate power and authority to enter into and carry out the terms of this
Agreement. The execution and delivery of this Agreement and the consummation of
the transactions contemplated hereby have been duly authorized by the respective
Boards of Directors of TCI and KTC (or an authorized committee thereof) and no
other corporate action on the part of TCI or KTC is necessary to authorize the
execution, delivery or performance by TCI or KTC of this Agreement.

          (b)  Binding Agreement.  This Agreement has been duly executed and
delivered by TCI and KTC and constitutes the valid and binding obligation of
each of TCI and KTC, enforceable against them in accordance with its terms.

          (c)  No Consents Needed. The execution, delivery and performance of
this Agreement by TCI and KTC does not require any consent, approval,
authorization of, or filing with or notification to, any Federal or state court
or governmental authority having jurisdiction over TCI or KTC, except for such
filings as may be required under the Securities Exchange Act of 1934, as
amended.

          (d)  Good Title.  KTC has on the date hereof, and will have at the
Closing, good and valid title to the KTC Series B Shares owned by it on the date
hereof, free and clear of any security interest, mortgage, pledge, lien, claim
or encumbrance of any kind (each, an "Encumbrance"). At the Closing, subject to
the terms and conditions of this Agreement, Malone will acquire good and valid
title to the KTC Series B Shares, free and clear of all Encumbrances.

          4.   Representations and Warranties of Malone.  Malone represents and
               -----------------------------------------                       
warrants to TCI and KTC as follows:

          (a)  Power and Authority. Malone has full legal capacity, right, power
and authority to enter into and carry out the terms and conditions of this
Agreement.

          (b)  Binding Agreement.  This Agreement has been duly executed and
delivered by Malone and constitutes the valid and binding obligation of him,
enforceable against him in accordance with its terms.

          (c)  No Consents Needed. The execution, delivery and performance of
this Agreement by Malone does not require any consent, approval, authorization
of, or filing with or notification to, any Federal or state court having
jurisdiction over him.

          (d)  Good Title.  Malone has, on the date hereof, and will have at the
Closing, good and valid title to the Malone Series A Shares, free and clear of
any Encumbrance.  At the Closing, subject to the terms and conditions of this
Agreement, KTC will acquire good and valid title to the Malone Series A Shares,
free and clear of all Encumbrances.

          5.   Termination.  This Agreement shall be terminated and the 
               ------------       
transactions contemplated hereby shall be abandoned with the mutual written
consent of TCI, KTC and Malone.

          6.   Governing Law.  This Agreement shall be governed by, and 
               --------------  
construed in accordance with, the laws of the State of Colorado, regardless of
the laws that might otherwise govern under applicable principles of conflicts of
law.

          7.   Counterparts.  This Agreement may be executed in two or more
               -------------                                               
counterparts, each of which shall be deemed an original but all of which
together shall constitute one and the same instrument.

                                       8
<PAGE>
 
          8.   Successors and Assigns.  This Agreement shall inure to the 
               -----------------------       
benefit of and be binding upon the parties hereto and their respective
successors, assigns, representatives and beneficiaries, but neither this
Agreement nor any of the rights, interests or other obligations hereunder shall
be assigned by any of the parties hereto without the prior written consent of
the other parties.

          9.   Amendment.  This Agreement may not be amended except by an 
               ----------                 
instrument in writing signed by each of the parties hereto.

          10.  Waiver.  Any party hereto may (i) extend the time for the 
               -------  
performance of any of the obligations or other acts of the other parties hereto,
(ii) waive any inaccuracies in the representations and warranties of the other
parties contained herein or in any document delivered pursuant hereto, and (iii)
waive compliance by the other parties with any of the agreements or conditions
contained herein. Any such extension or waiver shall be valid only if set forth
in an instrument in writing signed by the party or parties to be bound thereby.

          11.  Entire Agreement.  This Agreement constitutes the entire 
               -----------------  
agreement among the parties hereto and supersedes all prior agreements and
understandings, oral and written, among the parties with respect to the subject
matter hereof.


                                       9
<PAGE>
 
          IN WITNESS WHEREOF, the parties hereto have executed and delivered
this Agreement as of the date first above written.


                                   TELE-COMMUNICATIONS, INC.


                                   By:  
                                        -------------------------------
                                        Name:
                                        Title:

                                   KEARNS-TRIBUNE CORPORATION


                                   By:  
                                        -------------------------------
                                        Name:
                                        Title:



                                        -------------------------------
                                        JOHN C. MALONE


                                      10


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission